Androgen receptor‐neuroendocrine double‐negative tumor with squamous differentiation arising from treatment‐refractory metastatic castration‐resistant prostate cancer

INTRODUCTION: Treatment‐refractory metastatic castration‐resistant prostate cancer is a heterogeneous disease classified into androgen receptor‐high prostate cancer, androgen receptor‐low prostate cancer, amphicrine prostate cancer co‐expressing androgen receptor and neuroendocrine genes, double‐neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawazaki, Harutake, Asano, Atsushi, Kitamura, Yosuke, Katsuta, Jumpei, Ito, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560456/
https://www.ncbi.nlm.nih.gov/pubmed/34755072
http://dx.doi.org/10.1002/iju5.12363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560456/
https://www.ncbi.nlm.nih.gov/pubmed/34755072
http://dx.doi.org/10.1002/iju5.12363

Ejemplares similares